Alzheimer’s – media

Mouse study tests a novel approach against Alzheimer’s

Source:https://www.medicalnewstoday.com/articles/327291.php#1 Using mouse models of Alzheimer’s disease, researchers have been looking into a new approach to slow down the progression of this neurodegenerative disease — a ketone ester-rich diet.Could a new therapeutic approach help slow down Alzheimer’s disease? Researchers from the NIH investigate.To get the energy it needs to function correctly, the body usually relies on glucose (a simple sugar), which results from the digestion of carbohydrates. When there is not enough glucose to rely on, the body will burn fat instead. This is a process called ketosis, and it is the principle that ketogenic — or keto — diets rely on.Keto diets are typically low in carbohydrates and high in fats, and this imbalance in resources produces ketosis. But there is also another way of inducing ketosis that does not involve making this dietary shift. It involves taking supplements containing ketone ester, which have the same effect. Researchers have ...
- Source: drugdu
- 1,894
- December 13, 2019
Alzheimer's ketosis
A Scientifically-Supported App for Early Stage Dementia by SMART Brain Ageing

SMART Brain Aging, Inc. announced its one-on-one patient intervention program for aging brain health, Brain U Online, now available to adults above age 50 via online subscription and iOS app, Brain U Lite. Five years of clinical trials were carried out with more than 3,000 participants at Harvard Medical School/Boston University School of Medicine to develop this new program
- Source: HitConsultant
- 842
- July 10, 2018
Alzheimer's Clinical Trials Dementia mHealth
Epigenetic Dysregulation May Be Key to Onset

Greater than 90% of all Alzheimer’s disease (AD) cases are sporadic, meaning there are few hereditary risk factors for developing the disease. Although certain genetic variants increase the risk of AD, age is the strongest known risk factor. Yet, understanding how the underlying molecular mechanisms of aging predispose individuals to AD has remained elusive. Now, a team of researchers from the Perelman School of Medicine at the University of Pennsylvania have discovered what they believe are changes to the normal epigenetic landscape that lead to the onset of Alzheimer’s.
- Source: Pixabay
- 586
- March 9, 2018
Alzheimer's Researches
Gates streams $50m into Britain’s Dementia Discovery Fund

British venture the Dementia Discovery Fund (DDF) has received a $50 million investment from Bill Gates, to help fuel progress toward disease-modifying therapies for Alzheimer’s disease.
- Source: Pharmatimes
- 820
- November 14, 2017
Alzheimer's Market Views therapy
Amgen, Novartis Rev Up for New Alzheimer’s Study

Amgen and Basel, Switzerland-based Novartis announced they have expanded their collaboration with the Banner Alzheimer’s Institute (BAI) to launch a new clinical trial in Alzheimer’s.
- Source: Pharmalive
- 682
- November 6, 2017
Alzheimer's API Clinical Trial Market Views
Alzheimer’s–Brain’s protective mechanism revealed

Buildups of "clumpy" proteins in the brain are well-known hallmarks of Alzheimer's, but not everyone who has them goes on to develop this neurodegenerative disease. Why is that? New research investigates.
- Source: medicalnewstoday
- 625
- October 30, 2017
Alzheimer's dendritic spines neurodegenerative Researches
New study examines potential Alzheimer’s disease prevention strategies

The future of researching ways to prevent AD should probably focus on people at risk for developing the disease, said researchers, and should highlight how to improve management of chronic health conditions and education about living healthier.
- Source: news-medical
- 482
- August 10, 2017
Alzheimer's chronic Researches
US researchers say blood test can detect Alzheimer’s early

Researchers at Washington University School of Medicine in St Louis, US, have carried out a study to identify a rapid and inexpensive test for Alzheimer’s disease.
- Source: Medical devices
- 448
- July 21, 2017
Alzheimer's Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.